According to the Tianyancha app, Shanghai Fuzhenkang Biotechnology Co., Ltd. has been newly established, with Zhang Haitao serving as its legal representative and a registered capital of 1 million yuan. This company boasts a diverse portfolio of business operations, encompassing health consulting services, the sale of wearable smart devices, the distribution of artificial intelligence hardware, as well as the research and development of new material technologies. In terms of shareholder structure, Fosun Diagnostics Technology (Shanghai) Co., Ltd. holds an 80% stake, while Guangzhou Xingzhijian Health Management Co., Ltd. and Guangzhou Xingxiangjian Enterprise Management Partnership (Limited Partnership) each possess a 10% stake. A deeper equity analysis uncovers that Fosun Diagnostics Technology (Shanghai) Co., Ltd. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.